Skip to main content
OpenTrials

Clinical trial condition

Pancreatic Ductal Adenocarcinoma

Explore clinical trials studying Pancreatic Ductal Adenocarcinoma. Study availability and eligibility vary by location and protocol.

181 public trials 74 recruiting studies

Pancreatic Ductal Adenocarcinoma trial results

NCT04999761

Conditions
Advanced or Metastatic Solid Tumor, Alveolar Soft Part Sarcoma, Biliary Tract Cancer, +41 more
Locations
  • A site selected by Taiho Pharmaceutical Co., Ltd. Aichi, Japan
  • A site selected by Taiho Pharmaceutical Co., Ltd. Chiba, Japan
  • A site selected by Taiho Pharmaceutical Co., Ltd. Ehime, Japan
  • A site selected by Taiho Pharmaceutical Co., Ltd. Hokkaido, Japan
Conditions
Advanced Solid Tumors Cancer, Pancreatic Ductal Adenocarcinoma, RAS Mutation
Locations
  • Concord Cancer Centre, Concord Repatriation General Hospital, Sydney Local Health District Concord, New South Wales, Australia
  • Macquarie University / Clinical Trials Unit North Ryde, New South Wales, Australia
  • The Queen Elizabeth Hospital Woodville South, South Australia, Australia
  • Monash Health (Monash Medical Centre) Clayton, Victoria, Australia
View all 17 locations
Conditions
Pancreatic Ductal Adenocarcinoma
Locations
  • Universitätsklinikum Aachen, Studienzentrum Viszeralmedizin Klinik für Allgemeine-, Viszeral und Transplatationschirurgie Aachen, Germany
  • Universitätsklinikum Augsburg, III. medizinische Klinik Augsburg, Germany
  • St. Josef-Hospital, Klinikum der Ruhr-Universität Bochum, Abteilung für Hämatologie, Onkologie und Palliativmedizin, Studienambulanz Bochum, Germany
  • Universitätsklinikum Bonn, Chirurgische Abteilung Bonn, Germany
View all 33 locations